Paper40958744
Early diagnostic value of novel biomarkers for breast cancer therapy-related cardiac dysfunction.
Wang Z and 4 others. ESC Heart Fail, 2025. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Early diagnostic value of novel biomarkers for breast cancer therapy-related cardiac dysfunction. Papers, record 40958744. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40958744
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Early diagnostic value of novel biomarkers for breast cancer therapy-related cardiac dysfunction.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Humans | |
| Female | |
| Biomarkers | |
| Growth Differentiation Factor 15 | |
| Placenta Growth Factor | |
| Mendelian Randomization Analysis | |
| Peroxidase | |
| C-Reactive Protein | |
| Biomarkers, Tumor |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CSTB2023NSCO-MSX0219 | Natural Science Foundation of Chongqing, China | PubMed | ||
| 2023ZDXM011 | Chongqing Medical Scientific Research project (Joint project of Chongqing Health Commission and Science and Technology Bureau) | PubMed | ||
| W0188 | CQMU Program for Youth Innovation in Future Medicine | PubMed | ||
| KJQN202100462 | Youth Foundation of Chongqing Municipal Education Commission | PubMed | ||
| CYS240288 | Innovation Project of Graduate Student in Chongqing | PubMed |
Source PubMed
References62
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35087624 | Plasma biomarkers reflecting high oxidative stress in the prediction of myocardial injury due to anthracycline chemotherapy and the effect of carvedilol: insights from the CECCY Trial. | Oncotarget | 2022 | https://conductscience.org/library/papers/35087624 | PubMed |
| 2 | 22513938 | Trastuzumab containing regimens for early breast cancer. | Cochrane Database Syst Rev | 2012 | https://conductscience.org/library/papers/22513938 | PubMed |
| 3 | 34594039 | A cross-population atlas of genetic associations for 220 human phenotypes. | Nat Genet | 2021 | https://conductscience.org/library/papers/34594039 | PubMed |
| 4 | 32211421 | The Utility of Cardiac Reserve for the Early Detection of Cancer Treatment-Related Cardiac Dysfunction: A Comprehensive Overview. | Front Cardiovasc Med | 2020 | https://conductscience.org/library/papers/32211421 | PubMed |
| 5 | 26919165 | Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management. | CA Cancer J Clin | 2016 | https://conductscience.org/library/papers/26919165 | PubMed |
| 6 | 40958744 | Early diagnostic value of novel biomarkers for breast cancer therapy-related cardiac dysfunction. | ESC Heart Fail | 2025 | https://conductscience.org/library/papers/40958744 | PubMed |
| 7 | 29115294 | Placental growth factor and pre-eclampsia. | J Hum Hypertens | 2017 | https://conductscience.org/library/papers/29115294 | PubMed |
| 8 | 30167547 | Myeloperoxidase Inhibition Improves Ventricular Function and Remodeling After Experimental Myocardial Infarction. | JACC Basic Transl Sci | 2016 | https://conductscience.org/library/papers/30167547 | PubMed |
| 9 | 34859069 | Advances in Biomarkers for Detecting Early Cancer Treatment-Related Cardiac Dysfunction. | Front Cardiovasc Med | 2021 | https://conductscience.org/library/papers/34859069 | PubMed |
| 10 | 22476854 | High-sensitivity C-reactive protein (hs-CRP) as a biomarker for trastuzumab-induced cardiotoxicity in HER2-positive early-stage breast cancer: a pilot study. | Breast Cancer Res Treat | 2012 | https://conductscience.org/library/papers/22476854 | PubMed |
| 11 | 24291281 | Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab. | J Am Coll Cardiol | 2014 | https://conductscience.org/library/papers/24291281 | PubMed |
| 12 | 28570595 | Plasma brain natriuretic peptide levels are elevated in patients with cancer. | PLoS One | 2017 | https://conductscience.org/library/papers/28570595 | PubMed |
| 13 | 29344292 | Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update. | Theranostics | 2018 | https://conductscience.org/library/papers/29344292 | PubMed |
| 14 | 25948538 | Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. | Circulation | 2015 | https://conductscience.org/library/papers/25948538 | PubMed |
| 15 | 26220066 | Longitudinal Changes in Multiple Biomarkers Are Associated with Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin, Taxanes, and Trastuzumab. | Clin Chem | 2015 | https://conductscience.org/library/papers/26220066 | PubMed |
| 16 | 37741348 | Galectin-3 contributes to acute cardiac dysfunction and toxicity by increasing oxidative stress and fibrosis in doxorubicin-treated mice. | Int J Cardiol | 2023 | https://conductscience.org/library/papers/37741348 | PubMed |
| 17 | 36979345 | Diffuse Myocardial Fibrosis on Cardiac Magnetic Resonance Imaging Is Related to Galectin-3 and Predicts Outcome in Heart Failure. | Biomolecules | 2023 | https://conductscience.org/library/papers/36979345 | PubMed |
| 18 | 30797769 | Myeloperoxidase - A bridge linking inflammation and oxidative stress with cardiovascular disease. | Clin Chim Acta | 2019 | https://conductscience.org/library/papers/30797769 | PubMed |
| 19 | 19621070 | The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. | PLoS Med | 2009 | https://conductscience.org/library/papers/19621070 | PubMed |
| 20 | 27683581 | Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. | Stat Methods Med Res | 2018 | https://conductscience.org/library/papers/27683581 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42938808 | Precision Cardio-Oncology: A Multimodal Approach to Cancer Therapy-Related Cardiovascular Toxicity Prediction and Assessment. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42938808 | PubMed |
| 42813228 | Strain imaging in heart failure: from early detection to prognostic assessment. | ESC Heart Fail | 2026 | https://conductscience.org/library/papers/42813228 | PubMed |
| 42712801 | C-reactive protein in cardiovascular disease: clinical associations, conformation-dependent biology, and therapeutic perspectives. | Front Immunol | 2026 | https://conductscience.org/library/papers/42712801 | PubMed |
| 41711717 | Immune checkpoint inhibition and heart injury: molecular mechanisms and clinical challenges. | ESC Heart Fail | 2026 | https://conductscience.org/library/papers/41711717 | PubMed |
| 40958744 | Early diagnostic value of novel biomarkers for breast cancer therapy-related cardiac dysfunction. | ESC Heart Fail | 2025 | https://conductscience.org/library/papers/40958744 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 | NCBI Gene |
| GDF15 | 9518 | PubTator's text mining | https://conductscience.org/library/genes/9518 | NCBI Gene |
| LGALS3 | 3958 | PubTator's text mining | https://conductscience.org/library/genes/3958 | NCBI Gene |
| MPO | 4353 | PubTator's text mining | https://conductscience.org/library/genes/4353 | NCBI Gene |
| PGF | 5228 | PubTator's text mining | https://conductscience.org/library/genes/5228 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40958744
GET https://conductscience.org/api/papers/v1/40958744/references?page=2